Whistleblower Lawsuit Exposes Widespread Medicare Fraud by Cardiologists, Leading to $17.7 Million in Settlements
NEW YORK, December 21, 2024 – A groundbreaking False Claims Act lawsuit has shed light on a pervasive scheme of Medicare fraud involving hundreds of cardiologists across the United States. The U.S. Department of Justice today announced settlements with 16 groups of cardiologists totaling $17,761,564, resolving allegations that they systematically overcharged the government for radiopharmaceuticals used in common cardiac diagnostic testing. This marks a significant victory in the fight against healthcare fraud, but the battle is far from over. Hundreds more cardiologists implicated in the scheme will face litigation in what is shaping up to be an unprecedented qui tam action.
The lawsuit, spearheaded by two courageous cardiologist whistleblowers represented by Walden Macht Haran & Williams LLP (WMHW) and the Law Office of Henry Furst, alleges a blatant disregard for Medicare billing regulations. Cardiologists routinely utilize radiopharmaceuticals in nuclear stress tests, a vital diagnostic procedure. Medicare rules stipulate that reimbursement for these drugs should be based on the provider’s actual purchasing cost. However, the lawsuit contends that the implicated cardiologists grossly inflated their reimbursement claims, submitting bills far exceeding their expenses and pocketing millions of dollars in fraudulent overpayments.
This scheme highlights a disturbing trend of fraudulent practices within the cardiology field, prompting concerns about the financial integrity of government healthcare programs. As Dan Miller, partner at WMHW and lead counsel for the whistleblowers, stated, "Cardiology practices in the United States have repeatedly been accused of defrauding government healthcare programs; this is yet one more example of providers reaping profits while taxpayers foot the bill." The settlements announced today represent a significant step towards recouping taxpayer dollars and deterring future fraudulent activities, but the ongoing litigation against the remaining defendants underscores the magnitude of the problem.
The whistleblowers, whose identities remain protected under the False Claims Act, will receive over $2.7 million from the settlements as a reward for their crucial role in exposing the fraud. Their bravery in coming forward exemplifies the vital function whistleblowers play in safeguarding government healthcare programs. Mr. Miller emphasized the importance of whistleblowers, stating, "They are the key to maintaining the financial viability of government healthcare programs, so any providers or their employees who witness illegal behavior should strongly consider speaking up and taking action."
The ongoing litigation against the remaining hundreds of cardiologists will be closely watched. The case, United States ex rel. Walia v. Aaron et al. (D.D.C), No. 18-cv-00510-RJL, is being heard in the United States District Court for the District of Columbia. While the allegations are yet to be proven in court, the scale of the alleged fraud and the number of defendants involved suggest a systemic problem that demands a thorough investigation and appropriate legal action.
The WMHW whistleblower practice group, led by former prosecutor Dan Miller and Jonathan DeSantis, has a distinguished track record in qui tam litigation. The firm has recovered over $3 billion for state and federal governments, demonstrating their commitment to combating fraud and protecting taxpayer dollars. Notably, their success extends to cases initially declined by the government, highlighting their tenacity and expertise in pursuing complex whistleblower cases. This latest victory reinforces their reputation as a leading force in holding healthcare providers accountable and ensuring the integrity of government healthcare programs. The outcome of the ongoing litigation will undoubtedly have significant implications for the cardiology field and the broader healthcare industry, setting a precedent for future fraud enforcement actions.